Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Gusperimus trihydrochloride

EU orphan designation number: EU/3/01/034   
Active ingredient: Gusperimus trihydrochloride
Indication: Treatment of Wegener’s granulomatosis
Sponsor: Nordic Group B.V.
Siriusdreef 22, 2132 WT Hoofddorp, Nederland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
11/03/2001 Orphan designation EMEA/OD/057/00 (2001)947 of 29/03/2001
07/11/2011 Transfer of orphan designation EMEA/OD/057/00/T/01 (2011)7905 of 27/10/2011